Connor, Clark & Lunn Investment Management (CC&L)
ARVN icon

Connor, Clark & Lunn Investment Management (CC&L)’s Arvinas ARVN Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio ARVN Stock Details ARVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.39M Buy
167,056
+35,082
+27% +$327K ﹤0.01% 1107
2026
Q1 		$1.4M Buy
131,974
+30,136
+30% +$373K ﹤0.01% 1065
2025
Q4 		$1.21M Buy
101,838
+69,735
+217% +$761K ﹤0.01% 1078
2025
Q3 		$274K Sell
32,103
-54,100
-63% -$410K ﹤0.01% 1375
2025
Q2 		$634K Buy
+86,203
New +$635K ﹤0.01% 1187
2023
Q3 		– Sell
-40,076
Closed -$995K – 1360
2023
Q2 		$995K Sell
40,076
-101,015
-72% -$2.6M 0.01% 798
2023
Q1 		$3.85M Sell
141,091
-31,374
-18% -$991K 0.02% 417
2022
Q4 		$5.9M Sell
172,465
-19,245
-10% -$810K 0.03% 326
2022
Q3 		$8.53M Buy
191,710
+68,782
+56% +$3.34M 0.06% 229
2022
Q2 		$5.17M Buy
122,928
+42,578
+53% +$2.14M 0.03% 304
2022
Q1 		$5.41M Buy
80,350
+12,284
+18% +$837K 0.03% 314
2021
Q4 		$5.59M Buy
68,066
+37,280
+121% +$3.03M 0.03% 320
2021
Q3 		$2.53M Buy
+30,786
New +$2.72M 0.01% 477

Other funds holding ARVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s ARVN Position: Q2 2026 in Review

Connor, Clark & Lunn Investment Management (CC&L) increased its Arvinas (ARVN) stake by 27% in Q2 2026, buying an estimated $327K and bringing the position to 167,056 shares worth $1.39M. The position accounts for ﹤0.01% of the portfolio, ranked #1107.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in ARVN in Q3 2021 and has held it in 13 quarters since. The position peaked at $8.53M in Q3 2022. 200 funds tracked by Wall St. Rank hold ARVN as of Q2 2026.

  • Connor, Clark & Lunn Investment Management (CC&L) held 167,056 shares of Arvinas worth $1.39M as of Q2 2026.
  • Connor, Clark & Lunn Investment Management (CC&L) bought 35,082 Arvinas shares in Q2 2026, an estimated $327K.
  • Arvinas made up ﹤0.01% of Connor, Clark & Lunn Investment Management (CC&L)'s portfolio in Q2 2026, its #1107 holding.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Arvinas in Q3 2021 and has held it in 13 quarters since.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Arvinas position peaked at $8.53M in Q3 2022.
  • 200 funds tracked by Wall St. Rank held Arvinas as of Q2 2026.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2026, filed 13 Aug 2026.